Portfolio

Innovative Oncology therapies across multiple drug classes to improve patient lives

Small Molecule

Candidate Name

Class

Indication

Candidate Name

Class

Indication

Candidate name

EP0031

Indication

RET+ Solid Tumours

Phase 2

Large Molecule

Candidate Name

Class

Indication

Candidate Name

Class

Indication

Candidate name

EP0089

Indication

Solid Tumours

Phase 1